We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




MicroRNAs Regulate Response to Chronic Viral Infections

By LabMedica International staff writers
Posted on 23 Dec 2015
To study the role of microRNAs (miRNAs) in the cellular response to virus infection, researchers generated a vector that rapidly eliminated total cellular miRNA.

MicroRNAs are a class of about 20 nucleotides-long RNA fragments that block gene expression by attaching to molecules of messenger RNA (mRNA) in a fashion that prevents them from transmitting the protein synthesizing instructions they had received from the DNA. More...
With their capacity to fine-tune protein expression via sequence-specific interactions, miRNAs help regulate cell maintenance and differentiation. While some studies have also implicated miRNAs as regulators of the antiviral response, others have found that RISC (RNA-induced silencing complex), which facilitates miRNA-mediated silencing is rendered nonfunctional during cellular stress, including virus infection.

To determine the global role of miRNAs in the cellular response to virus infection, investigators at the Icahn School of Medicine at Mount Sinai (New York, NY, USA) generated a poxvirus gene vector that rapidly eliminated total cellular miRNA populations in terminally differentiated primary cultures.

They reported in the December 9, 2015, issue of the journal Cell Host & Microbe that loss of miRNAs had a negligible impact on both innate sensing of and immediate response to acute viral infection. In contrast, miRNA depletion specifically enhanced cytokine expression, providing a posttranslational mechanism for immune cell activation during cellular stress.

Overall, the results highlighted the physiological role of miRNAs during the antiviral response and suggested that their contribution was limited to chronic infections and the acute activation of the adaptive immune response.

“Apart from their roles in causing medical maladies, viruses have long been used as tools to reveal unappreciated aspects of biology, providing us with insights into the many unknowns of how our cells function,” said senior author Dr. Benjamin tenOever, professor of microbiology at the Icahn School of Medicine at Mount. “We developed a tool based on a poxvirus gene that allows us to manipulate microRNA populations in any tissue or cell type we desire.”

Related Links:

Icahn School of Medicine at Mount Sinai



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.